RecruitingNCT06476145

Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation

Prospective Randomized Controlled Trial Evaluating Adenoma Recurrence After Endoscopic Mucosal Resection With Margin Marking or Post Treatment With Snare Tip Soft Coagulation


Sponsor

AdventHealth

Enrollment

342 participants

Start Date

Dec 8, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Non-inferiority trial comparing the recurrence rate of adenomas in non-pedunculated colonic lesions following endoscopic mucosal resection with margin marking (EMR-MM) and endoscopic mucosal resection with thermal margin ablation (EMR-STSC)


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Age 18 years or older
  • Ability to provide informed consent
  • Patient scheduled to undergo colonoscopy for the evaluation and removal of colon polyps
  • Non-pedunculated polyps ≥ 20 mm size

Exclusion Criteria6

  • Pedunculated polyps
  • Inflammatory bowel disease
  • Inability to provide informed consent
  • Lesions < 20 mm in size (largest dimension)
  • Lesion involves the lips of the ileocecal valve, is located at the appendiceal orifice and/or is fully circumferential.
  • Any standard contraindication, including pregnancy, to anesthesia and/or colonoscopy

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

AdventHealth

Orlando, Florida, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06476145


Related Trials